Outcome of sequential autologous stem cell transplantation on aggressive non-Hodgkin lymphoma-a sing

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:dengdq123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Aim Retrospectively analyzethe role of sequential autologous stem cell transplantation (ASCT) in aggressive NHL.Method 121 newly diagnosed patients with aggressive NHL,including 68 males and 53 females with median age of 42 years (15-63 years old) from March 2007 to December 2013 in our center.
其他文献
Introduction Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most effective means for curing hematological malignancy.Immunologic reconstitution (IR) posttransplant plays
会议
Mesenchymal stem cells (MSCs) are a promising candidate for cellular therapies.Co-transplantation of MSCs and hematopoietic stem cells (HSCs) promotes successful engraftment and improves hematopoietic
会议
Reduced intensity (RIT) conditioning regimens whether improve patients quality of life (QoL).Quality of Life Questionnaire analysis showed 35 the RIT patients were able to perform their normal work an
会议
Objective To evaluate the response rate and survival rate of refractory or relapsed HL patients treated with autologous peripheral blood stem cell transplantation(APBSCT).Methods From January 2004 to
会议
Objective Umbilical cord blood transplantation (UCBT) has extended the availability of allogeneic HSCT to patients who would not otherwise be eligible for this curative approach because of the lack of
会议
Objective Unrelated donor cord blood transplantation (CBT),as an alternative matched-unrelated or mismatched-related peripheral blood or bone marrow transplantation,has become a widely accepted treatm
会议
Umbilical cord blood transplantation (UCBT) is increasingly used as an alternative treatment for hematologic malignancies.However,the simple parameters for predicting the outcomes of patients after UC
会议
This study included data from 185 consecutively treated patients,16 years of age or older,who underwent myeloablative transplantation using unrelated UCB (UCBT,n=70) or HLA-identical sibling donor per
会议
Chemotherapy can increase treatment-related mortality associated with future hematopoietic stem cell transplantation (HSCT) for patients with relapsed/refractory acute myeloid leukemia (AML).There is
会议
Objective Observe the clinical effect of haploidentical HSCT (haplo-HSCT) to treat pediatric leukemia.Method During July 2007 to September 2011,24 children were subjected in haploidentical HSCT.Then,t
会议